Unknown

Dataset Information

0

KRAS oncogene repression in colon cancer cell lines by G-quadruplex binding indolo[3,2-c]quinolines.

ABSTRACT: KRAS is one of the most frequently mutated oncogenes in human cancer, yet remaining undruggable. To explore a new therapeutic strategy, a library of 5-methyl-indolo[3,2-c]quinoline derivatives (IQc) with a range of alkyldiamine side chains was designed to target DNA and RNA G-quadruplexes (G4) in the promoter and 5'-UTR mRNA of the KRAS gene. Biophysical experiments showed that di-substituted IQc compounds are potent and selective KRAS G4 stabilizers. They preferentially inhibit the proliferation of KRAS mutant cancer cell lines (0.22 < IC50 < 4.80 ?M), down-regulate KRAS promoter activity in a luciferase reporter assay, and reduce both KRAS mRNA and p21(KRAS) steady-state levels in mutant KRAS colon cancer cell lines. Additionally, IQcs induce cancer cell death by apoptosis, explained in part by their capacity to repress KRAS expression. Overall, the results suggest that targeting mutant KRAS at the gene level with G4 binding small molecules is a promising anticancer strategy.

SUBMITTER: Lavrado J 

PROVIDER: S-EPMC5382548 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

KRAS oncogene repression in colon cancer cell lines by G-quadruplex binding indolo[3,2-c]quinolines.

Lavrado João J   Brito Hugo H   Borralho Pedro M PM   Ohnmacht Stephan A SA   Kim Nam-Soon NS   Leitão Clara C   Pisco Sílvia S   Gunaratnam Mekala M   Rodrigues Cecília M P CM   Moreira Rui R   Neidle Stephen S   Paulo Alexandra A  

Scientific reports 20150408

KRAS is one of the most frequently mutated oncogenes in human cancer, yet remaining undruggable. To explore a new therapeutic strategy, a library of 5-methyl-indolo[3,2-c]quinoline derivatives (IQc) with a range of alkyldiamine side chains was designed to target DNA and RNA G-quadruplexes (G4) in the promoter and 5'-UTR mRNA of the KRAS gene. Biophysical experiments showed that di-substituted IQc compounds are potent and selective KRAS G4 stabilizers. They preferentially inhibit the proliferatio  ...[more]

Similar Datasets

Unknown Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives.
| S-EPMC4449006 | biostudies-literature
Unknown Organometallic indolo[3,2-c]quinolines versus indolo[3,2-d]benzazepines: synthesis, structural and spectroscopic characterization, and biological efficacy.
| S-EPMC2908761 | biostudies-literature
Unknown Ruthenium- and Osmium-Arene Complexes of 2-Substituted Indolo[3,2-c]quinolines: Synthesis, Structure, Spectroscopic Properties, and Antiproliferative Activity.
| S-EPMC3022494 | biostudies-literature
Unknown Transition-metal-free [3 + 3] annulation of indol-2-ylmethyl carbanions to nitroarenes. A novel synthesis of indolo[3,2-b]quinolines (quindolines).
| S-EPMC5789443 | biostudies-literature
Unknown Dicopper(II) and dizinc(II) complexes with nonsymmetric dinucleating ligands based on indolo[3,2-c]quinolines: synthesis, structure, cytotoxicity, and intracellular distribution.
| S-EPMC3763518 | biostudies-other
Unknown Ruthenium- and osmium-arene complexes of 8-substituted indolo[3,2-<i>c</i>]quinolines: Synthesis, X-ray diffraction structures, spectroscopic properties, and antiproliferative activity.
| S-EPMC3587412 | biostudies-literature
Unknown 5,11-Dimethyl-6,12-dimeth-oxy-indolo[3,2-b]carbazole.
| S-EPMC3569787 | biostudies-literature
Unknown Synthesis and DNA binding profile of N-mono- and N,N'-disubstituted indolo[3,2-b]carbazoles.
| S-EPMC4339310 | biostudies-literature
Unknown 6,12-Bis(hex-yloxy)-5H,11H-indolo[3,2-b]carbazole.
| S-EPMC3588340 | biostudies-literature
Unknown Oncogenic KRAS regulates BMP4 expression in colon cancer cell lines.
| S-EPMC3362092 | biostudies-literature